Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice

BACKGROUND: Clinical trials have indicated that preclinical results obtained with human tumor xenografts in mouse models may overstate the potential of adenovirus (Ad)-mediated oncolytic therapies. We have previously demonstrated that the replication of human Ads depends on cyclin E dysregulation or...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Pei-Hsin, Rao, Xiao-Mei, Wechman, Stephen L., Li, Xiao-Feng, McMasters, Kelly M., Zhou, Heshan Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609153/
https://www.ncbi.nlm.nih.gov/pubmed/26475304
http://dx.doi.org/10.1186/s12885-015-1731-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609153/
https://www.ncbi.nlm.nih.gov/pubmed/26475304
http://dx.doi.org/10.1186/s12885-015-1731-x

Ejemplares similares